Allscripts hosts Investor Conference in New York City

Go back to Allscripts hosts Investor Conference in New York City

Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting

March 22, 2017 7:34 AM UTC

Cantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company indicated that its customer satisfaction scores among US acute care hospitals improved by 16% in 2016 vs. 2015 levels. MDRX is also leveraging its investments in dbMotion... More

Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day

March 22, 2017 7:01 AM UTC

Jefferies reiterated a Buy rating and $16.50 price target on Allscripts (NASDAQ: MDRX) following the company's investor day.

Analyst Sean Dodge commented, "MDRX is firmly on a path toward more sustainable revenue growth which when coupled with its lean cost structure should... More